title: Anti-tumour activity of heat-shock protein 60-recognizing CD4+ T cells against syngeneic murine renal cell carcinoma.
abstract: OBJECTIVE
  To determine whether heat-shock protein (HSP) 60-recognizing CD4(+) T cells show antitumour activity against renal carcinoma (RENCA) cells, as HSP is highly expressed by tumour cells and induced in cells by various stresses, including transformation.
  
  
  METHODS
  RENCA, a renal cortical adenocarcinoma cell line of BALB/c origin, was used. Expression of major histocompatibility complex (MHC) class I, class II and HSP-60 on RENCA tumour cells was analysed by flow cytometry. BASL1.1, an autoreactive T-helper type 1 type CD4(+) T cell clone established by us, and that recognises HSP-60, was also used for a tumour-neutralising assay.
  
  
  RESULTS
  The RENCA cells were negative for MHC class II, but expressed intracellular HSP-60. In the tumour-neutralising assay, BASL1.1 cells significantly suppressed the in vivo growth of RENCA cells. Three of five mice rejected RENCA cells when co-inoculated with BASL1.1 cells.
  
  
  CONCLUSIONS
  These results indicate that HSP-60-recognizing CD4(+) T cells have the potential to eliminate renal cell carcinoma in vivo and that the eliciting of an anti-self T cell response at the tumour site can lead to regression of renal cancer.
authors.affiliation: Department of Urology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. etom@uro.med.kyushu-u.ac.jp
authors.forename: Masatoshi
authors.initials: M
authors.lastname: Eto
authors.forename: Mamoru
authors.initials: M
authors.lastname: Harada
authors.forename: Katsunori
authors.initials: K
authors.lastname: Tatsugami
authors.forename: Masahiko
authors.initials: M
authors.lastname: Harano
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Koga
authors.forename: Goro
authors.initials: G
authors.lastname: Matsuzaki
authors.forename: Seiji
authors.initials: S
authors.lastname: Naito
mesh_terms: D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D002292:Carcinoma, Renal Cell / Q000276:immunology / Q000628:therapy*; D018834:Chaperonin 60 / Q000276:immunology*; D005260:Female; D005434:Flow Cytometry / Q000379:methods; D005805:Genes, MHC Class I / Q000276:immunology; D005802:Genes, MHC Class II / Q000276:immunology; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D051379:Mice; D008807:Mice, Inbred BALB C
chemical_list: D018834:Chaperonin 60